Large-scale testing (Phase 3)UnknownNCT05911061
What this trial is testing
A Phase Ⅲ Clinical Trial of Recombinant COVID-19 Trivalent (XBB+BA.5+Delta) Protein Vaccine (Sf9 Cell) in Booster Vaccination
Who this might be right for
COVID-19
WestVac Biopharma Co., Ltd. 4,950